Patents by Inventor Jose Miguel LIZCANO DE VEGA

Jose Miguel LIZCANO DE VEGA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240350449
    Abstract: A pharmaceutical combination comprising (A): a polyunsaturated fatty acid and (B): a chemotherapeutic agent compound for the simultaneous, separate or sequential use in the treatment of a cancer in a human patient.
    Type: Application
    Filed: July 3, 2024
    Publication date: October 24, 2024
    Applicant: ABILITY PHARMACEUTICALS S.L.
    Inventors: Carles DOMÈNECH GARCIA, José Alberto ALFÓN CORIAT, Héctor PÉREZ MONTOYO, Miguel Francisco SEGURA GINARD, Jose Miguel LIZCANO DE VEGA
  • Patent number: 12053449
    Abstract: A pharmaceutical combination comprising (A): a polyunsaturated fatty acid and (B): a chemotherapeutic agent compound for the simultaneous, separate or sequential use in the treatment of a cancer in a human patient.
    Type: Grant
    Filed: January 21, 2022
    Date of Patent: August 6, 2024
    Assignee: ABILITY PHARMACEUTICALS S.L.
    Inventors: Carles Domènech Garcia, José Alberto Alfón Coriat, Héctor Pérez Montoyo, Miguel Francisco Segura Ginard, Jose Miguel Lizcano De Vega
  • Publication number: 20220257554
    Abstract: A pharmaceutical combination comprising (A): a polyunsaturated fatty acid and (B): a chemotherapeutic agent compound for the simultaneous, separate or sequential use in the treatment of a cancer in a human patient.
    Type: Application
    Filed: January 21, 2022
    Publication date: August 18, 2022
    Applicant: ABILITY PHARMACEUTICALS S.L.
    Inventors: Carles DOMÈNECH GARCIA, José Alberto ALFÓN CORIAT, Héctor PÉREZ MONTOYO, Miguel Francisco SEGURA GINARD, Jose Miguel LIZCANO DE VEGA
  • Patent number: 11260042
    Abstract: A pharmaceutical combination comprising (A): a polyunsaturated fatty acid and (B): a chemotherapeutic agent compound for the simultaneous, separate or sequential use in the treatment of a cancer in a human patient.
    Type: Grant
    Filed: May 15, 2018
    Date of Patent: March 1, 2022
    Assignee: ABILITY PHARMACEUTICALS S.L.
    Inventors: Carles Domènech Garcia, José Alberto Alfón Coriat, Héctor Pérez Montoyo, Miguel Francisco Segura Ginard, Jose Miguel Lizcano De Vega
  • Publication number: 20210154166
    Abstract: A pharmaceutical combination comprising (A): a polyunsaturated fatty acid and (B): a chemotherapeutic agent compound for the simultaneous, separate or sequential use in the treatment of a cancer in a human patient.
    Type: Application
    Filed: May 15, 2018
    Publication date: May 27, 2021
    Applicant: ABILITY PHARMACEUTICALS S.L.
    Inventors: Carles DOMÈNECH GARCIA, José Alberto ALFÓN CORIAT, Héctor PÉREZ MONTOYO, Miguel Francisco SEGURA GINARD, Jose Miguel LIZCANO DE VEGA